Drug News

Added 16 hours ago Drug news

China’s National Medical Products Administration has accepted an application for the approval of denosumab copy biological HLX 14.- Shanghai Henlius Biotech

China’s National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), has accepted an application for the...

Added 16 hours ago Drug news

FDA accepts Genentech’s NDA for Xofluza for the treatment of influenza in children- Genentech/Roche

Genentech, a member of the Roche Group announced that the FDA has accepted a New Drug Application (NDA) as well...

Added 16 hours ago Drug news

CHMP recommends Zolgensma for the treatment of patients with 5q spinal muscular atrophy . - Novartis

AveXis, a Novartis company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

Added 16 hours ago Drug news

CHMP recommends Zeposia to treat adult patients with relapsing remitting multiple sclerosis.- BMS

Bristol Myers Squibb announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has...

Added 16 hours ago Drug news

CHMP recommends Cosentyx for the treatment of adult patients with active non-radiographic axial spondyloarthritis. -Novartis

Novartis, announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...

Added 16 hours ago Drug news

Sanofi receives positive CHMP opinion for Sarclisa for the treatment of relapsed and refractory multiple myeloma.

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sarclisa (isatuximab)....

Added 1 day ago Drug news

FDA approves Zeposia to treat relapsing forms of multiple sclerosis ,including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.-BMS

Bristol-Myers Squibb Company announced that the FDA approved Zeposia (ozanimod) 0.92 mg for the treatment of adults with relapsing forms...

Added 1 day ago Drug news

EU gives CE mark approval to SARS-CoV-2 test for Coronavirus.- Thermo Fisher

Thermo Fisher Scientific Inc announced that it has received the CE mark in the European Union for its diagnostic test...

Added 1 day ago Drug news

Interim analysis in phase III OVAL study of VB 111 shows positive outcome in ovarian cancer.- VBL Therapeutics

VBL Therapeutics announced an encouraging outcome of the planned interim analysis in the phase III OVAL study, a double-blind controlled...

Added 1 day ago Drug news

Data from two Phase III trials in adult and pediatric patients for MM 36 showed statistically significant improvements in atopic dermatitis.- Medimetriks Pharmaceuticals

Medimetriks Pharmaceuticals announced that its partner, Otsuka Pharmaceuticals Co. Ltd., achieved positive results in two Phase III Japanese clinical trials...

Search all news articles